Clinical management of uterine papillary serous carcinoma

被引:15
作者
Roelofsen, Thijs [1 ]
van Ham, Maaike A. [1 ]
de Hullu, Joanne A. [1 ]
Massuger, Leon F. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol 791, NL-6500 HB Nijmegen, Netherlands
关键词
comprehensive surgical staging; cytoreductive surgery; endometrial cancer; papillary serous carcinoma; radiation therapy; uterine chemotherapy; PLATINUM-BASED CHEMOTHERAPY; CLEAR-CELL CARCINOMA; WHOLE ABDOMINOPELVIC RADIATION; EPITHELIAL OVARIAN-CARCINOMA; GYNECOLOGIC-ONCOLOGY-GROUP; LONG-TERM SURVIVAL; STAGE-I PATIENTS; ENDOMETRIAL CANCER; NEOADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY;
D O I
10.1586/ERA.10.199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uterine papillary serous carcinoma (UPSC) is an aggressive variant of endometrial cancer. Owing to its rarity, most clinicians are unfamiliar with the clinical aspects and management of UPSC. Furthermore, little prospective evidence exists regarding how best to treat this subset of patients. In anticipation of prospective clinical trials, this article summarizes the latest results of various clinical management options in the different substages of UPSC, with a special focus on the effects of cytoreductive surgery, comprehensive surgical staging and different adjuvant treatment options in relation to recurrence rate and survival outcome.
引用
收藏
页码:71 / 81
页数:11
相关论文
共 94 条
[11]   The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma [J].
Cirisano, FD ;
Robboy, SJ ;
Dodge, RK ;
Bentley, RC ;
Krigman, HR ;
Synan, IS ;
Soper, JT ;
Clarke-Pearson, DL .
GYNECOLOGIC ONCOLOGY, 2000, 77 (01) :55-65
[12]   Non-endometrioid carcinomas of the uterine corpus: A review of their pathology with emphasis on recent advances and problematic aspects [J].
Clement, PB ;
Young, RH .
ADVANCES IN ANATOMIC PATHOLOGY, 2004, 11 (03) :117-142
[13]   Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium [J].
Creasman, WT ;
Kohler, MF ;
Odicino, F ;
Maisonneuve, P ;
Boyle, P .
GYNECOLOGIC ONCOLOGY, 2004, 95 (03) :593-596
[14]   Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma? [J].
Despierre, E ;
Moerman, P ;
Vergote, I ;
Amant, F .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 :273-277
[15]   The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC) [J].
Dietrich, CS ;
Modesitt, SC ;
DePriest, PD ;
Ueland, FR ;
Wilder, J ;
Reedy, MB ;
Pavlik, EJ ;
Kryscio, R ;
Cibull, M ;
Giesler, J ;
Manahan, K ;
Huh, W ;
Cohn, D ;
Powell, M ;
Slomovitz, B ;
Higgins, R ;
Merritt, W ;
Hunter, J ;
Puls, L ;
Gehrig, P ;
van Nagell, JR .
GYNECOLOGIC ONCOLOGY, 2005, 99 (03) :557-563
[16]   High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer [J].
DuBeshter, B ;
Estler, K ;
Altobelli, K ;
McDonald, S ;
Glantz, C ;
Angel, C .
GYNECOLOGIC ONCOLOGY, 2004, 94 (02) :383-386
[17]  
Dunton C J, 1991, Obstet Gynecol Surv, V46, P97, DOI 10.1097/00006254-199102000-00014
[18]   Optimal management for surgically Stage 1 serous cancer of the uterus [J].
Elit, L ;
Kwon, J ;
Bentley, J ;
Trim, K ;
Ackerman, I ;
Carey, M .
GYNECOLOGIC ONCOLOGY, 2004, 92 (01) :240-246
[19]   An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC) [J].
Fader, Amanda Nickles ;
Starks, David ;
Gehrig, Paola A. ;
Secord, Angeles Alvarez ;
Frasure, Heidi E. ;
O'Malley, David M. ;
Tuller, Erin R. ;
Rose, Peter G. ;
Havrilesky, Laura J. ;
Moore, Kathleen N. ;
Huh, Warner K. ;
Axtell, Allison E. ;
Kelley, Joseph L. ;
Zanotti, Kristine M. .
GYNECOLOGIC ONCOLOGY, 2009, 115 (02) :244-248
[20]   Platinum/Taxane-based Chemotherapy With or Without Radiation Therapy Favorably Impacts Survival Outcomes in Stage I Uterine Papillary Serous Carcinoma [J].
Fader, Amanda Nickles ;
Drake, Richard D. ;
O'Malley, David M. ;
Gibbons, Heidi E. ;
Huh, Warner K. ;
Havrilesky, Laura J. ;
Gehrig, Paola A. ;
Tuller, Erin ;
Axtell, Allison E. ;
Zanotti, Kristine M. .
CANCER, 2009, 115 (10) :2119-2127